Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1985-12-19
|
pubmed:abstractText |
To examine the beta-adrenergic effects of the catecholamines in poorly controlled diabetes, we have studied insulin-deprived alloxan-diabetic (A-D) dogs during 90 min of moderate exercise (100 m/min, 10-12 degrees) alone (C) or with propranolol (5 micrograms . kg-1 . min-1) (P) or combined P and somatostatin infusion (0.5 microgram . kg-1 . min-1) (P + St). In P, in contrast to C, immunoreactive glucagon (IRG) rose only after 50 min of exercise. However, hepatic glucose production (Ra) rose normally. In P + St, IRG fell 50% below basal, and the Ra response to exercise was abolished. Interestingly, in P and P + St, glucose metabolic clearance rate (MCR) rose by 400% above the inadequate MCR response to exercise in C, despite 30% lower insulin levels. Compared with C, free fatty acids (FFA) and lactate were sharply reduced during P and P + St. Plasma glucose (G) did not change in C, but due to elevated glucose uptake, G fell over 120 mg/dl in P, and due to diminished Ra, G fell 170 mg/dl in P + St. Norepinephrine was similar in all groups. Epinephrine and cortisol were higher in P + St by 90 min of exercise, perhaps as a result of hypoglycemia. In summary, during exercise in poorly controlled A-D dogs, beta-blockade does not appear to affect Ra; beta-blockade leads to diminished mobilization of extrahepatic substrate as evidenced by reduced FFA and lactate levels; beta-blockade increases MCR to levels seen in normal dogs during exercise alone.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Epinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Nonesterified,
http://linkedlifedata.com/resource/pubmed/chemical/Glucagon,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Lactates,
http://linkedlifedata.com/resource/pubmed/chemical/Lactic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Propranolol,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta,
http://linkedlifedata.com/resource/pubmed/chemical/Somatostatin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
8750-7587
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1282-9
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:2865246-Animals,
pubmed-meshheading:2865246-Blood Glucose,
pubmed-meshheading:2865246-Diabetes Mellitus, Experimental,
pubmed-meshheading:2865246-Dogs,
pubmed-meshheading:2865246-Epinephrine,
pubmed-meshheading:2865246-Fatty Acids, Nonesterified,
pubmed-meshheading:2865246-Glucagon,
pubmed-meshheading:2865246-Glucose,
pubmed-meshheading:2865246-Kinetics,
pubmed-meshheading:2865246-Lactates,
pubmed-meshheading:2865246-Lactic Acid,
pubmed-meshheading:2865246-Liver,
pubmed-meshheading:2865246-Male,
pubmed-meshheading:2865246-Norepinephrine,
pubmed-meshheading:2865246-Physical Exertion,
pubmed-meshheading:2865246-Propranolol,
pubmed-meshheading:2865246-Receptors, Adrenergic, beta,
pubmed-meshheading:2865246-Somatostatin
|
pubmed:year |
1985
|
pubmed:articleTitle |
Role of beta-adrenergic mechanisms during exercise in poorly controlled diabetes.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|